  |
Items where Author is "Muramatsu, Hiromi"
Group by: Item Type | No Grouping Jump to: Article Number of items: 3. ArticleCastadno, Diana and Bettini, Emily and Kumar, Binod and Chudnovskiy, Aleksey and Siv, Anna and Protti, Giulia and Nakadakari-Higa, Sandra and Ceglia, Simona and De, Luna Nina and Chiu, Joy E. and Lederer, Katlyn and Li, Shuk Hang and Ibrahim, Hassaan and Muramatsu, Hiromi and Mdluli, Thandiswa and Ábrahám, Edit and Sahingur, Sinem E. and Maillard, Ivan and Tam, Ying K. and Shin, Sunny and Hensley, Scott E. and Miner, Jonathan J. and Lipinszki, Zoltán and Reboldi, Andrea and Pardi, Norbert and Spreafico, Roberto and Victora, Gabriel D. and Locci, Michela (2025) Distinct components of mRNA vaccines cooperate to instruct efficient germinal center responses. CELL, 188 (26). pp. 7461-7480. ISSN 0092-8674 Montoya, Brian and Melo-Silva, Carolina R. and Tang, Lingjuan and Kafle, Samita and Lidskiy, Peter and Bajusz, Csaba and Vadovics, Mate and Muramatsu, Hiromi and Ábrahám, Edit and Lipinszki, Zoltán and Chatterjee, Debotri and Scher, Gabrielle and Benitez, Juliana and Sung, Molly M. H. and Tam, Ying K. and Catanzaro, Nicholas J. and Schaefer, Alexandra and Andino, Raul and Baric, Ralph S. and Martinez, David R. and Pardi, Norbert and Sigal, Luis J. (2024) mRNA-LNP vaccine-induced CD8+T cells protect mice from lethal SARS-CoV-2 infection in the absence of specific antibodies. MOLECULAR THERAPY, 32 (6). pp. 1790-1804. ISSN 1525-0016 Muramatsu, Hiromi and Lam, Kieu and Bajusz, Csaba and Laczkó, Dorottya and Karikó, Katalin (2022) Lyophilization provides long-term stability for a lipid nanoparticle-formulated, nucleoside-modified mRNA vaccine. MOLECULAR THERAPY, 30 (5). pp. 1941-1951. ISSN 1525-0016 |
